The EU requires MAHs (marketing authorisation holders) to submit a variety of structured data to the authorities in the future. One area is the identification of medicinal products (IDMP) on the European market.
The core idea behind IDMP is an in-depth knowledge of the medicinal products on the market with a special focus on their composition and their pharmacovigilance.
For the implementation of this IDMP initiative, the EU is consolidating five ISO standards. It is mandatory that the IDMP initiative is implemented by the pharmaceutical companies concerned by the deadline.
Other authorities around the world will follow, wanting similar data reported. Pharmaceutical companies are faced with the challenge of efficiently managing the growing amount of structured data, but also using it profitably to optimise processes in the company (keyword: Big Data).
With the SAP Cloud Application Polaris, SAP partner Gramont has developed software that can consolidate, prepare and electronically transmit this data to the authorities in a very flexible way – and this completely integrated into their SAP landscape with the same Fiori look and feel.